The human cancer and stem cell marker podocalyxin interacts with the glucose-3-transporter in malignant pluripotent stem cells

Biochem Biophys Res Commun. 2010 Jul 30;398(3):372-6. doi: 10.1016/j.bbrc.2010.06.074. Epub 2010 Jun 22.

Abstract

Podocalyxin, an integral plasma membrane cell-adhesion glycoprotein, is a marker of human pluripotent and multipotent stem cells. Podocalyxin is also a marker of many types of cancers and its expression correlates with an aggressive and poor-prognosis tumor phenotype. The function of podocalyxin in stem cells and malignant cells is unknown. Protein sequence data obtained from purified podocalyxin protein isolated from embryonal carcinoma cancer stem cells reveals peptide sequence data for the glucose-3-transporter. Protein-precipitation experiments of embryonal carcinoma protein extracts identify a podocalyxin/glucose-3-transporter protein complex. Cell imaging studies demonstrate co-localization of podocalyxin and glucose-3-transporter and confirm the interaction in vivo. Finally, siRNA podocalyxin-knockdown experiments show decreased expression levels of the glucose-3-transporter. These findings suggest a novel interaction of the glucose-3-transporter and the cell-adhesion protein podocalyxin. In pluripotent stem cells and in human cancer disease, podocalyxin may function in part to regulate and maintain the cell surface expression of the glucose-3-transporter.

MeSH terms

  • Amino Acid Sequence
  • Biomarkers, Tumor / metabolism*
  • Cell Line, Tumor
  • Gene Knockdown Techniques
  • Glucose Transporter Type 3 / metabolism*
  • Humans
  • Neoplasms / metabolism*
  • Neoplastic Stem Cells / metabolism*
  • Pluripotent Stem Cells / metabolism*
  • RNA, Small Interfering / genetics
  • Sialoglycoproteins / genetics
  • Sialoglycoproteins / metabolism*

Substances

  • Biomarkers, Tumor
  • Glucose Transporter Type 3
  • RNA, Small Interfering
  • Sialoglycoproteins
  • podocalyxin